Class IOngoingD-0207-2025
Drug recall · January 29, 2025
FOUZEE SugarLin HERBAL FORMULA capsules recall
Why: Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7
- Lots / codes
Batch # 001, exp. date 09/10/2026
- Quantity
- 172 180-count bottles
- Company
- Shoppers- Plaza, Hawthorne, CA
- Distribution
- Nationwide via internet sales
- Initiated
- December 16, 2024 · Voluntary: Firm initiated
- Classified
- January 22, 2025
- Reported
- January 29, 2025
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.